BioSpace News Archive

Name change honors Tyson’s support for creating a new, nimble and diverse generation of tech-enabled physicians poised to be advocates for their patients and communities [18-November-2019] OAKLAND, Calif. , Nov. 18, 2019 /PRNewswire/ -- The Kaiser Permanente School of Medicine will be named in honor of late Kaiser Permanente Chairman and CEO Bernard J. Tyson , r

Liminal BioSciences Inc. announced the presentation of two scientific posters with new preclinical data for PBI-4050 and the treatment of pulmonary arterial hypertension at the American Heart Association 2019 conference taking place on November 16-18, 2019 in Philadelphia, PA..

Pomerantz LLP announces that a class action lawsuit has been filed against Zynerba Pharmaceuticals, Inc. and certain of its officers.

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Eliezer Zomer, Ph.D., Vice President, Discovery Research and Product Development for Galectin Therapeutics, will be presenting at the 3rd Annual Anti-Fibrotic Drug Development (AFDD) Summit, held from Nov 18 - 20, 2019 at Revere Hotel Boston Common in Boston, Massachusetts

Codiak BioSciences, Inc., a company at the forefront of advancing engineered exosomes as a new class of biologic medicines, today announced the first preclinical data for its engEx™ Platform program, exoASO™.

Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Mark Demitrack, M.D., Senior Vice President and Chief Medical Officer, will present at the Stifel 2019 Healthcare Conference, sponsored by Stifel,

The Association of Physician Assistants in Oncology (APAO) and Horizon CME (HCME) jointly announce a partnership to provide education to the APAO membership through HCME’s Advanced Practice Provider (APP) Oncology Summit (APPOS) series and its associated online library

Minnesota Grocery/Pharmacy chain Coborn’s launches their new $9.99 Diabetes Management Program to help customers better afford and manage diabetes.

Liminal BioSciences Inc. announced that members of the management team will provide a business overview and update at the Jefferies 2019 London Healthcare Conference at 18:00 GMT on Wednesday, November 20, 2019 in London, UK.